Skip to main content
. 2017 Jan 23;2017:7513687. doi: 10.1155/2017/7513687

Table 1.

CD-19 designs for leukemia.

MSKCC NCI UPenn
Design CD28-19-28z CD28-FMC63-28Z 4-1BB-CD19-BB
Vector Retrovirus Retrovirus Lentivirus
Expression Approx. 30 days Approx. 30 days >4 years
CR in ALL 90% 80% 90%
CR in CLL 0/8 4/14
PR in CLL 0/8 4/14
OOR in CLL 0.00% 57%

CR: complete response, ALL: acute lymphocytic leukemia, CLL: chronic lymphocytic leukemia, PR: partial response, and ORR: overall response rate.